what is glp 1 and gip receptor agonist Frontiers Possible mechanisms of action of
Description
In the brain, neurons involved in appetite control have devoted GLP-1 receptors
The analysis included 3,845,171 patients with type 2 diabetes, of whom 15.1% were prescribed a GLP-1 RA, including 6.6% who received dulaglutide, 4.9% who received semaglutide, 4.2% who received liraglutide, and 2.1% who received exenatide
Some laboratory studies have shown that GLP-1 analogs may reduce cartilage degradation and synovial inflammation in experimental arthritis models
SGLT-2 inhibitors were associated with lower risk of renal outcome as compared with placebo (36% lower risk), DPP-4 inhibitors (40% lower risk) and GLP-1RA (22% lower risk)
Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome
The effect of adding exenatide to thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial
